Lumexa Imaging Holdings, Inc. Common Stock

NASDAQ:LMRI

Medical - Devices

Healthcare
$14.01 +7.25%

+$0.84 today

Market cap
$1.35B
Beta
2.18
P/E (TTM)
-34.3
EPS (TTM)
-$0.28
52W Low $6.45High $19.45

Volume 0.26M

Average 0.92M

LMRI Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Lumexa Imaging Holdings, Inc. Common StockNASDAQ: LMRI

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development of $0 in Q1 FY2026

Q1 FY2026 research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 2 fiscal years.
  • FY2025 was the highest annual figure in the 3 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How LMRI compares with its peers on the latest reported figures

  • LMRI's FY2025 research & development of $0 is the highest of the 2 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for LMRI, versus a peer median of 0.0%.
LMRI Competitors Peer median
Research & Development for LMRI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LMRILumexa Imaging Holdings, Inc. Common StockFY2025$0 ——0.0%
RDNTRadNet, Inc.LTM Sep 2026$0 ——0.0%
Peer median (excluding LMRI) $0——0.0%

Competitors are the stored peer set for LMRI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue935.93M948.87M1.02B
Cost of Revenue836.96M852.61M905.9M
Gross Profit98.97M96.26M117.19M
Gross Margin10.6%10.1%11.5%
Research & Development000
Selling, General & Admin55.17M70.36M90.45M
Operating Expenses76.52M41.02M90.45M
Depreciation & Amortization72.14M57.16M55.39M
EBITDA94.58M114M141.71M
EBITDA Margin10.1%12.0%13.9%
Operating Income22.45M55.24M26.73M
Operating Margin2.4%5.8%2.6%
Interest Income000
Interest Expense141.69M136.03M118.54M
Other Income / Expenses(141.69M)(134.44M)(58.95M)
Income Before Tax(119.25M)(79.19M)(32.22M)
Pre-Tax Margin-12.7%-8.3%-3.1%
Income Tax Expense2.98M14.91M14.89M
Net Income(122.23M)(94.1M)(47.1M)
Net Margin-13.1%-9.9%-4.6%
EPS (Basic)(1.29)(1.00)(0.66)
EPS (Diluted)(1.29)(1.00)(0.66)
Weighted Avg Shares94.57M94.57M70.98M
Weighted Avg Shares (Diluted)94.57M94.57M70.98M

Lumexa Imaging Holdings, Inc. Common Stock

NASDAQ:LMRI

Intrinsic Alpha fair value

Locked

Current Price

$14.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.